Early Trial of mRNA Vaccine for Pancreatic Cancer Shows Potential
Summary
Pancreatic cancer is one of the most deadly cancers, with a 13% survival rate at five years. But the ability of scientists to custom-design therapeutic vaccines...
Description
Pancreatic cancer is one of the most deadly cancers, with a 13% survival rate at five years. But the ability of scientists to custom-design therapeutic vaccines...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source